IP Library Granted Patent US 7,345,159
Granted Patent B2
US 7,345,159 · App. 10/702,203 · Granted Mar 18, 2008

Massive parallel method for decoding DNA and RNA

Assignee: The Trustees of Columbia University in the City of New York
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,345,159
App. No.
10/702,203
Granted
Mar 18, 2008
Kind
B2
Abstract

This invention provides methods for attaching a nucleic acid to a solid surface and for sequencing nucleic acid by detecting the identity of each nucleotide analogue after the nucleotide analogue is incorporated into a growing strand of DNA in a polymerase reaction. The invention also provides nucleotide analogues which comprise unique labels attached to the nucleotide analogue through a cleavable linker, and a cleavable chemical group to cap the —OH group at the 3′-position of the deoxyribose.

Claims (34)

1. A nucleotide analogue which comprises:

(a) a base which is an adenine, an analogue of adenine, a cytosine, an analogue of cytosine, a guanine, an analogue of guanine, a thymine, an analogue of thymine, a uracil, or an analogue of uracil;

(b) a unique label attached through a cleavable linker to the base or to the analogue of the base;

(c) a deoxyribose;

(d) a —OR group at a 3′-position of the deoxyribose, wherein R is —CH 2 OCH 3 or —CH 2 CH═CH 2; and

(e) a triphosphate group.

2. The nucleotide analogue of claim 1 , wherein the unique label is a fluorescent moiety or a fluorescent semiconductor crystal.

3. The nucleotide analogue of claim 2 , wherein the fluorescent moiety is 5-carboxyfluorescein, 6-carboxyrhodamine-6G, N,N,N′,N′-tetramethyl-6-carboxyrhodamine, or 6-carboxy-X-rhodamine.

4. The nucleotide analogue of claim 1 , wherein the unique label is a fluorescence energy transfer tag which comprises an energy transfer donor and an energy transfer acceptor.

5. The nucleotide analogue of claim 4 , wherein the energy transfer donor is 5-carboxyfluorescein or cyanine, and wherein the energy transfer acceptor is selected from the group consisting of dichiorocarboxyfluorescein, dichloro-6-carboxyrhodamine-6G, dichloro-N,N,N′,N′-tetramethyl-6-carboxyrhodamine, and dichloro-6-carboxy-X-rhodamine.

6. The nucleotide analogue of claim 1 , wherein the unique label is a mass tag that can be detected and differentiated by a mass spectrometer.

7. The nucleotide analogue of claim 6 , wherein the mass tag is a 2-nitro-α-methyl-benzyl group, a 2-nitro-α-methyl-3-fluorobenzyl group, a 2-nitro-α-methyl-3,4-difluorobenzyl group, or a 2-nitro-α-methyl-3,4-dimethoxybenzyl group.

8. The nucleotide analogue of claim 1 , wherein the unique label is attached through a cleavable linker to a 5-position of cytosine or thymine or to a 7-position of deaza-adenine or deaza-guanine.

9. The nucleotide analogue of claim 1 , wherein the cleavable linker between the unique label and the nucleotide analogue is cleavable by one or more of a physical means, a chemical means, a physical chemical means, heat, or light.

10. The nucleotide analogue of claim 9 , wherein the cleavable linker is a photocleavable linker which comprises a 2-nitrobenzyl moiety.

11. The nucleotide analogue of claim 1 , wherein the nucleotide analogue has the structure:

wherein Dye1, Dye2, Dye3, and Dye4 are four different dye labels; and wherein R is —CH 2 OCH 3 or —CH 2 CH═CH 2 .

12. The nucleotide analogue of claim 11 , wherein the nucleotide analogue has the structure:

wherein R is —CH 2 OCH 3 or —CH 2 CH═CH 2 .

13. The nucleotide analogue of claim 1 , wherein the nucleotide analogue has the structure:

wherein Tag1, Tag2, Tag3, and Tag4 are four different mass tag labels; and wherein R is —CH 2 OCH 3 or —CH 2 CH═CH 2 .

14. The nucleotide analogue of claim 13 , wherein the nucleotide analogue has the structure:

wherein R is —CH 2 OCH 3 or —CH 2 CH═CH 2 .

15. A nucleotide analogue which comprises:

(a) a base which is an adenine, an analogue of adenine, a cytosine, an analogue of cytosine, a guanine, an analogue of guanine, a thymine, an analogue of thymine, a uracil, or analogue of uracil;

(b) a unique label attached through a cleavable linker to the base or to the analogue of the base;

(c) a deoxyribose;

(d) a —OR group at a 3′-position of the deoxyribose, wherein R is a cleavable chemical group; and

(e) a triphosphate group,

wherein the nucleotide analogue has the structure:

 wherein Dye1, Dye2, Dye3, and Dye4 are four different dye labels.

16. The nucleotide analogue of claim 15 , wherein the cleavable chemical group is cleavable by one or more of a physical means, a chemical means, a physical chemical means, heat, or light.

17. The nucleotide analogue of claim 15 , wherein the dye is 5-carboxyfluorescein, 6-carboxyrhodamine-6G, N,N,N′,N′-tetramethyl-6-carboxyrhodamine, or 6-carboxy-X-rhodamine.

18. The nucleotide analogue of claim 15 , wherein R is —CH 2 OCH 3 or —CH 2 CH═CH 2 .

Assignments (1)
CONFIRMATORY LICENSE Recorded Feb 6, 2008
From: NATIONAL SCIENCE FOUNDATION
To: MORNINGSIDE, COLUMBIA UNIVERSITY OF NY
Reel/Frame 020469/0223 →
Continuity (4)
Division 0997236400 · Oct 5, 2001
Continuation In Part 0968467000 · Oct 6, 2000
Provisional Application 6030089400 · Jun 26, 2001
Related Publication 20040185466A1 · Sep 23, 2004